High Rates of Pneumocystis carinii Pneumonia in Allogeneic Blood and Marrow Transplant Recipients Receiving Dapsone Prophylaxis
Open Access
- 1 December 1999
- journal article
- research article
- Published by Oxford University Press (OUP) in Clinical Infectious Diseases
- Vol. 29 (6), 1467-1471
- https://doi.org/10.1086/313509
Abstract
Chemoprophylaxis for Pneumocystis carinii pneumonia (PCP) is routinely given after allogeneic blood or marrow transplantation. We evaluated the effectiveness of dapsone prophylaxis (50 mg orally twice daily, 3 times per week) compared with twice-weekly trimethoprim-sulfamethoxazole (TMP-SMZ) in preventing PCP after allogeneic blood or marrow transplantation. Patients included all (n = 646) who received allogeneic blood or marrow transplants between 1 September 1993 and 31 December 1996 who survived at least 100 days after transplantation. A cohort of 111 dapsone recipients was compared with the remaining 535 who received TMP-SMZ. Ten patients developed PCP; 8 were taking dapsone. PCP incidence in the TMP-SMZ cohort was 0.37% versus 7.2% for dapsone. The relative risk for PCP associated with dapsone use was 18.8 (P < .001) and was not accounted for by age, clinical extensive chronic graft-versus-host disease, donor source, or malignant relapse. Dapsone prophylaxis at this dosage is associated with significantly higher rates of PCP than is TMP-SMZ after allogeneic marrow transplantation. We advise caution in prescribing alternatives to TMP-SMZ prophylaxis in this setting.This publication has 24 references indexed in Scilit:
- Atovaquone Compared with Dapsone for the Prevention ofPneumocystis cariniiPneumonia in Patients with HIV Infection Who Cannot Tolerate Trimethoprim, Sulfonamides, or BothThe New England Journal of Medicine, 1998
- Dapsone for Pneumocystis carinii prophylaxis in children undergoing bone marrow transplantationBone Marrow Transplantation, 1997
- Aerosolized pentamidine, cotrimoxazole and dapsone-pyrimethamine for primary prophylaxis of Pneumocystis carinii pneumonia and toxoplasmic encephalitisAIDS, 1995
- A Randomized Trial of Three Antipneumocystis Agents in Patients with Advanced Human Immunodeficiency Virus InfectionThe New England Journal of Medicine, 1995
- Thrice-weekly cotrimoxazole is better than weekly dapsone—pyrimethamine for the primary prevention of Pneumocystis carinii pneumonia in HIV-infected patientsAIDS, 1993
- Utility of dapsone for prophylaxis of Pneumocystis carinii pneumonia in trimethoprim-sulfamethoxazole-intolerant, HIV-infected individualsAIDS, 1993
- Primary prophylaxis for Pneumocystis carinii pneumoniaAIDS, 1993
- Oral dapsone versus nebulized pentamidine for Pneumocystis carinii pneumonia prophylaxisAIDS, 1992
- Oral administration of cyclosporin A for recipients of allogeneic marrow transplants: implications of clinical gut dysfunctionBritish Journal of Haematology, 1984